Syndax

Reimagining Cancer Treatment

Syndax is a commercial-stage oncology innovator developing first-in-class therapies for areas of significant unmet need, including acute leukemia and chronic graft-versus-host disease. The company works to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients.

Partnerships